Roberta Magliozzi

A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosis

Blood and CSF biomarkers for multiple sclerosis: emerging clinical applications

Intrathecal Inflammatory Profile and Gray Matter Damage Predict Progression Independent of Relapse Activity in Early Multiple Sclerosis

Mapping Molecular Pathways of Multiple Sclerosis: A Gene Prioritization and Network Analysis of White Matter Pathology Transcriptomics

Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis

snRNA-seq stratifies multiple sclerosis patients into distinct white matter glial responses

Neuropathological and cerebrospinal fluid correlates of choroid plexus inflammation in progressive multiple sclerosis

Characterization of cortico-meningeal translocator protein expression in multiple sclerosis

Meningeal inflammation as a driver of cortical grey matter pathology and clinical progression in multiple sclerosis

Myeloid cell iron uptake pathways and paramagnetic rim formation in multiple sclerosis

Comparing the Pathology, Clinical, and Demographic Characteristics of Younger and Older‐Onset Multiple Sclerosis

High Levels of Perivascular Inflammation and Active Demyelinating Lesions at Time of Death Associated with Rapidly Progressive Multiple Sclerosis Disease Course: A Retrospective Postmortem Cohort Study

“Ependymal‐in” Gradient of Thalamic Damage in Progressive Multiple Sclerosis

The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome

B cell rich meningeal inflammation associates with increased spinal cord pathology in multiple sclerosis

The <scp>CSF</scp> Profile Linked to Cortical Damage Predicts Multiple Sclerosis Activity

The Vascular Side of Chronic Bed Rest: When a Therapeutic Approach Becomes Deleterious

Meningeal inflammation changes the balance of TNF signalling in cortical grey matter in multiple sclerosis

Inflammatory intrathecal profiles and cortical damage in multiple sclerosis

Meningeal inflammation and cortical demyelination in acute multiple sclerosis

The cortical damage, early relapses, and onset of the progressive phase in multiple sclerosis

Programmed death 1 is highly expressed on <scp>CD</scp>8⁺<scp>CD</scp>57⁺ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein–Barr virus

Cognitive impairment predicts disability progression and cortical thinning in MS: An 8-year study

Epilepsy in multiple sclerosis: The role of temporal lobe damage

Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients

Cortical grey matter demyelination can be induced by elevated pro-inflammatory cytokines in the subarachnoid space of MOG-immunized rats

Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis